Biofrontera Inc. Payments To Acquire Equity Securities Fv Ni
Biofrontera Inc. (BFRI) reported Payments To Acquire Equity Securities Fv Ni of $50.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2024-08-14
- Biofrontera Inc. payments to acquire equity securities fv ni for fiscal 2022 was $5.12M.
| Period end | Payments To Acquire Equity Securities Fv Ni 6 month | Payments To Acquire Equity Securities Fv Ni 12 month |
|---|---|---|
| 2024-06-30 | $50.00K 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $5.12M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |